Table 2 Mortality in the bronchiectasis cohort relative to the matched cohort.

From: Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities

 

Total

(N = 29,646)

Male

(n = 14,307)

Female

(n = 15,339)

No. at risk

No. of death

IR (/100,000 PY)

HRa

95% CI

No. at risk

No. of death

IR (/100,000 PY)

HRa

95% CI

No. at risk

No. of death

IR (/100,000 PY)

HRa

95% CI

Overall

Matched

14,823

2058

2142.2

Ref

Ref

7153

1250

2781.3

Ref

Ref

7670

808

1580.4

Ref

Ref

BE

14,823

2250

2505.1

1.15

1.09–1.22

7154

1405

3362.0

1.19

1.10–1.29

7669

845

1759.5

1.10

0.99–1.21

Age group

< 60 years

 Matched

7179

246

485.8

Ref

Ref

3398

168

713.6

Ref

Ref

3781

78

287.8

Ref

Ref

 BE

7177

274

569.7

1.17

0.98–1.39

3394

195

872.2

1.22

0.99–1.51

3783

79

306.9

1.05

0.77–1.44

≥ 60 years

 Matched

7644

1812

3989.0

Ref

Ref

3755

1082

5056.4

Ref

Ref

3889

730

3038.3

Ref

Ref

 BE

7646

1976

4736.5

1.17

1.10–1.25

3760

1210

6226.5

1.21

1.12–1.32

3886

766

3437.2

1.12

1.01–1.24

  1. Data are presented as risk ratios (95% confidence interval).
  2. aUnadjusted hazard ratio.
  3. BE, bronchiectasis; IR, incidence rate; PY, person-years; HR, hazard ratio; CI, confidence interval; Ref, reference.
Back to article page